Purpose

The goal is to determine whether armodafinil is helpful in alleviating clinically significant fatigue in patients with HIV/AIDS.

Type of Study: Clinical Trial
Setting of Study: outpatient
Clinical Trials.gov number: 4839
Providing Clinical Treatment?: Yes
No Cost Treatment?: Yes

Study Activities

Filling Out Forms
Computer Tasks
Blood Samples
Provides Payment: Reimbursement for transportation
Provides Payment: Compensation for study related procedures

Eligibility

Ages Eligible for Study: 18 Years - 70 Years
Genders Eligible for Study: Both
This study is not recruiting Healthy Volunteers.

Criteria

Inclusion Criteria:
HIV+
Clinically significant fatigue (Score of 41+ on Fatigue Severity Scale)
Speaks English
Able and willing to give informed consent
Fecund women using barrier methods of contraception

Location: 1051 Riverside Drive Unit 51 NY NY 10032
Clinic: Depression Evaluation Service
Division: Therapeutics

Study chairs or principal investigators:
Judith Godwin Rabkin Ph.D., M.P.H., Principal Investigator

Co-investigators:
Richard Rabkin,
Martin McElhiney,
Patrick McGrath,